| Authors: |
Wu Y; Department of Bioengineering, Stanford University, Stanford, CA, USA.; Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, USA., Wang P; Department of Chemical Engineering, Stanford University, Stanford, CA, USA., Liu LX; Department of Neurobiology, Stanford University, Stanford, CA, USA., Song D; Department of Neurobiology, Stanford University, Stanford, CA, USA., Qin Q; Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China., Gao C; Promega Corporation, San Luis Obispo, CA, USA., Hageman M; Promega Corporation, San Luis Obispo, CA, USA., Kirkland TA; Promega Corporation, Madison, WI, USA., Su Y; Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.; Department of Nuclear Medicine, Zhongshan Hospital, Shanghai, China., Lin MZ; Department of Bioengineering, Stanford University, Stanford, CA, USA. mzlin@stanford.edu.; Department of Neurobiology, Stanford University, Stanford, CA, USA. mzlin@stanford.edu.; Department of Pediatrics, Stanford University, Stanford, CA, USA. mzlin@stanford.edu.; Department of Chemical and Systems Biology, Stanford University, Stanford, CA, USA. mzlin@stanford.edu. |
